Read the full story at YourStory
This is a headline and a short summary only. The full article, photographs and reporting belong to YourStory, so it opens on their website.
Read the full story at YourStory →ImmunitoAI’s platform designs antibodies for specific disease targets, which the startup then tests in its own laboratory.
Indian News is a news aggregator. The headline, this summary and the link are taken from
YourStory’s public news feed, which the publisher offers for exactly this
purpose. Nothing has been rewritten, and no article text or photograph is stored on this site.